{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:16:26Z","timestamp":1773929786940,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31201338"],"award-info":[{"award-number":["31201338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013352","name":"Weihai Science and Technology Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019MH048"],"award-info":[{"award-number":["ZR2019MH048"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuint.2025.106103","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:44:09Z","timestamp":1765471449000},"page":"106103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Astaxanthin inhibits the aggregation and cytotoxicity of tau4RD\u0394K280 via possible interaction with the aggregation-prone segments"],"prefix":"10.1016","volume":"192","author":[{"given":"Huahua","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-0092","authenticated-orcid":false,"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2025.106103_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jlcr.3819","article-title":"Tau protein targeting via radioiodinated azure A for brain theranostics: radiolabeling, molecular docking, in vitro and in vivo biological evaluation","volume":"63","author":"Abdelaziz","year":"2020","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"10.1016\/j.neuint.2025.106103_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2019.01.010","article-title":"In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (A\u03b21-42) toxicity and aggregation","volume":"124","author":"Alghazwi","year":"2019","journal-title":"Neurochem. Int."},{"issue":"45","key":"10.1016\/j.neuint.2025.106103_bib3","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1021\/bi0011330","article-title":"Amyloid fibril formation by A\u03b216-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR","volume":"39","author":"Balbach","year":"2000","journal-title":"Biochemistry."},{"issue":"38","key":"10.1016\/j.neuint.2025.106103_bib4","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1021\/bi000850r","article-title":"Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias","volume":"39","author":"Barghorn","year":"2000","journal-title":"Biochemistry."},{"key":"10.1016\/j.neuint.2025.106103_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102017","article-title":"A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies","volume":"90","author":"Basha","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"21","key":"10.1016\/j.neuint.2025.106103_bib6","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acschemneuro.0c00531","article-title":"Sowing the seeds of discovery: tau-propagation models of alzheimer's disease","volume":"11","author":"Bell","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2025.106103_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging."},{"issue":"19","key":"10.1016\/j.neuint.2025.106103_bib8","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1021\/acs.jafc.8b00988","article-title":"Effects of astaxanthin and docosahexaenoic-acid-acylated astaxanthin on Alzheimer's disease in APP\/PS1 double-transgenic mice","volume":"66","author":"Che","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.neuint.2025.106103_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1017\/S0007114510003454","article-title":"Pharmacokinetics and first-pass metabolism of astaxanthin in rats","volume":"105","author":"Choi","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.neuint.2025.106103_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuint.2025.106103_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3945\/ajcn.115.115477","article-title":"Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)","volume":"103","author":"Coombes","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"46","key":"10.1016\/j.neuint.2025.106103_bib12","doi-asserted-by":"crossref","first-page":"27331","DOI":"10.1039\/D0RA03809A","article-title":"Residue-based propensity of aggregation in the tau amyloidogenic hexapeptides AcPHF6 and AcPHF6","volume":"10","author":"Dangi","year":"2020","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.neuint.2025.106103_bib13","article-title":"Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials","volume":"166","author":"Donoso","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7662","key":"10.1016\/j.neuint.2025.106103_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature."},{"issue":"13","key":"10.1016\/j.neuint.2025.106103_bib15","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acs.jpcb.5b00175","article-title":"Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3","volume":"119","author":"Ganguly","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.neuint.2025.106103_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137532","article-title":"Alzheimer's disease: the role of proteins in formation, mechanisms, and new therapeutic approaches","volume":"817","author":"Gholami","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2025.106103_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fneur.2018.00070","article-title":"Tau filaments and the development of positron emission tomography tracers","volume":"9","author":"Goedert","year":"2018","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2025.106103_bib18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1046\/j.1471-4159.2000.0752155.x","article-title":"Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and Parkinsonism linked to chromosome 17 mutations","volume":"75","author":"Goedert","year":"2000","journal-title":"J. Neurochem."},{"issue":"6359","key":"10.1016\/j.neuint.2025.106103_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","article-title":"Fibril structure of amyloid-\u03b2 (1\u201342) by cryo-electron microscopy","volume":"358","author":"Gremer","year":"2017","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.neuint.2025.106103_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-4580(99)00063-9","article-title":"Memory and mental status correlates of modified braak staging","volume":"20","author":"Grober","year":"1999","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.neuint.2025.106103_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fphar.2020.00307","article-title":"Astaxanthin ameliorated parvalbumin-positive neuron deficits and alzheimer's disease-related pathological progression in the hippocampus of app(NL-G-F\/NL-G-F) mice","volume":"11","author":"Hongo","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuint.2025.106103_bib22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/alz.12453","article-title":"A critical appraisal of tau-targeting therapies for primary and secondary tauopathies","volume":"18","author":"Imbimbo","year":"2022","journal-title":"Alzheimer's Dement."},{"issue":"1","key":"10.1016\/j.neuint.2025.106103_bib23","article-title":"Molecular simulation for food protein-ligand interactions: a comprehensive review on principles, current applications, and emerging trends. Compr. Rev. Food Sci","volume":"23","author":"Jin","year":"2024","journal-title":"Food Saf."},{"issue":"Pt A","key":"10.1016\/j.neuint.2025.106103_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2022.11.031","article-title":"Protein misfolding and related human diseases: a comprehensive review of toxicity, proteins involved, and current therapeutic strategies","volume":"223","author":"Khan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuint.2025.106103_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101924","article-title":"Nature's toolbox against tau aggregation: an updated review of current research","volume":"87","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.neuint.2025.106103_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1074\/jbc.M507753200","article-title":"Inducible expression of tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs","volume":"281","author":"Khlistunova","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106103_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113865","article-title":"Dual modulators of aggregation and dissociation of amyloid beta and tau: in vitro, in vivo, and in silico studies of uncaria rhynchophylla and its bioactive components","volume":"156","author":"Kim","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3\u20134","key":"10.1016\/j.neuint.2025.106103_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jemt.20188","article-title":"Characterization of paired helical filaments by scanning transmission electron microscopy","volume":"67","author":"Ksiezak-Reding","year":"2005","journal-title":"Microsc. Res. Tech."},{"issue":"1","key":"10.1016\/j.neuint.2025.106103_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-191201","article-title":"Is the p3 peptide (A\u03b217-40, A\u03b217-42) relevant to the pathology of Alzheimer's disease?","volume":"74","author":"Kuhn","year":"2020","journal-title":"J. Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neuint.2025.106103_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-021-01127-4","article-title":"Alzheimer's disease brain contains tau fractions with differential prion-like activities","volume":"9","author":"Li","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"48","key":"10.1016\/j.neuint.2025.106103_bib31","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","article-title":"3D structure of Alzheimer's amyloid-beta(1-42) fibrils","volume":"102","author":"L\u00fchrs","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"21","key":"10.1016\/j.neuint.2025.106103_bib32","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cbic.202100287","article-title":"Potent tau aggregation inhibitor D-peptides selected against tau-repeat 2 using mirror image phage display","volume":"22","author":"Malhis","year":"2021","journal-title":"Chembiochem."},{"key":"10.1016\/j.neuint.2025.106103_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep30182","article-title":"A critical role for the self-assembly of amyloid-\u03b21-42 in neurodegeneration","volume":"6","author":"Marshall","year":"2016","journal-title":"Sci. Rep."},{"issue":"32","key":"10.1016\/j.neuint.2025.106103_bib34","doi-asserted-by":"crossref","first-page":"11153","DOI":"10.1080\/10408398.2022.2092446","article-title":"Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer's disease","volume":"63","author":"Nagaraju","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"23","key":"10.1016\/j.neuint.2025.106103_bib35","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1007\/s00018-021-03954-z","article-title":"Amyloid \u03b2 structural polymorphism, associated toxicity and therapeutic strategies","volume":"78","author":"Oren","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2025.106103_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-7075-7-18","article-title":"Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans","volume":"7","author":"Park","year":"2010","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.neuint.2025.106103_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neurobiolaging.2017.04.022","article-title":"Time course of tau toxicity and pharmacologic prevention in a cell model of tauopathy","volume":"57","author":"Pickhardt","year":"2017","journal-title":"Neurobiol. Aging."},{"issue":"45","key":"10.1016\/j.neuint.2025.106103_bib38","doi-asserted-by":"crossref","first-page":"38948","DOI":"10.1074\/jbc.M111.271874","article-title":"Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by tau protein","volume":"286","author":"Ramachandran","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106103_bib39","series-title":"Protein Folding Dynamics and Stability: Experimental and Computational Methods","first-page":"107","article-title":"Molecular dynamics simulation to study protein conformation and ligand interaction","author":"Sasidharan","year":"2023"},{"issue":"6968","key":"10.1016\/j.neuint.2025.106103_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"Selkoe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106103_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176962","article-title":"Astaxanthin inhibits apoptosis in a cell model of tauopathy by attenuating endoplasmic reticulum stress and unfolded protein response","volume":"983","author":"Shi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2025.106103_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/ijms25020831","article-title":"Modulation of tau pathology in Alzheimer'S disease by dietary bioactive compounds","volume":"25","author":"Shi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuint.2025.106103_bib43","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.fct.2008.05.038","article-title":"Safety assessment of astaxanthin-rich microalgae biomass: acute and subchronic toxicity studies in rats","volume":"46","author":"Stewart","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.neuint.2025.106103_bib44","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.neuint.2025.106103_bib45","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming \u03b2 structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"34","key":"10.1016\/j.neuint.2025.106103_bib46","doi-asserted-by":"crossref","first-page":"E4976","DOI":"10.1073\/pnas.1600749113","article-title":"Atomic-resolution structure of a disease-relevant A\u03b2 (1-42) amyloid fibril","volume":"113","author":"W\u00e4lti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.neuint.2025.106103_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.118.3.573","article-title":"Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro","volume":"118","author":"Wille","year":"1992","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.neuint.2025.106103_bib48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.14283\/jpad.2022.63","article-title":"Oral tau aggregation inhibitor for Alzheimer's disease: design, progress and basis for selection of the 16 mg\/day dose in a phase 3, randomized, placebo-controlled trial of hydromethylthionine mesylate","volume":"9","author":"Wischik","year":"2022","journal-title":"J. Prev. Alzheimers Dis"},{"issue":"20","key":"10.1016\/j.neuint.2025.106103_bib49","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Nat. Acad. Sci. U S A"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:16:50Z","timestamp":1773919010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0197018625001767"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106103","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astaxanthin inhibits the aggregation and cytotoxicity of tau4RD\u0394K280 via possible interaction with the aggregation-prone segments","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106103"}}